Skip to content
Research Article Open access CC BY 4.0

Oral Mucormycosis: Post Complication of COVID Era

Ankita Garg, Satendra Sharma, Shailendra Singh Chauhan, Aditya Sinha, Mohan Rawat, . Deepika

International Journal of Research and Reports in Dentistry · pp. 155–163 · Published 5 Aug 2021

Abstract

Mucormycosis is an invasive and potentially lethal fungal infection and a rare terminal complication of uncontrolled diabetes and other chronic debilitating diseases. The incidence of disease has increased considerably due to widespread use of antibiotics, steroids and longterm use of humidifiers in corona positive patients. Despite surgical and antifungal treatments the mortality rate is higher than 50% and even higher in immunocompromised patients. The role of dentist is of immense importance because mucormycosis primarily occurs around rhinomaxillary or rhino cerebral areas involving facial tissues, palate, alveolar bone and mandibular bone. The present article briefly reviews pathogenesis, signs and symptoms, risks and complications, diagnosis and the management of the mucormycosis.

Oral Mucormycosis Covid-19 Diabetes Antifungal therapy

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.